Laura Frias

La Paz, MD 28046, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer.

Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer.

Journal: Current oncology (Toronto, Ont.)
Published: December 01, 2025

Current Indications for Seed-Marked Axillary Lymph Node Dissection in Breast Cancer.

Current Indications for Seed-Marked Axillary Lymph Node Dissection in Breast Cancer.

Journal: Cancers
Published: March 25, 2025

A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict® Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma.

A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict® Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma.

Journal: Cancers
Published: December 04, 2024

Breast-Conserving Surgery Guided with Magnetic Seeds vs. Wires: A Single-Institution Experience.

Breast-Conserving Surgery Guided with Magnetic Seeds vs. Wires: A Single-Institution Experience.

Journal: Cancers
Published: December 16, 2023

Surgical Interest of an Accurate Real-World Prediction of Primary Systemic Therapy Response in HER2 Breast Cancers.

Surgical Interest of an Accurate Real-World Prediction of Primary Systemic Therapy Response in HER2 Breast Cancers.

Journal: Cancers
Published: April 16, 2023

The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study.

The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study.

Journal: Current oncology (Toronto, Ont.)
Published: February 14, 2022

A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.

A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 01, 2018

Document of standardization of enteral nutrition access in adults.

Document of standardization of enteral nutrition access in adults.

Journal: Nutricion hospitalaria
Published: August 20, 2014
Showing 1-8 of 8

Last Updated: 09/26/2026